CAC
SBC

Cowen and Company’s SBC Medical Group SBC Stock Holding History

Cowen and Company’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-109,214
Closed -$1.14M – 629
2023
Q1 		$1.14M Buy
+109,214
New +$1.13M 0.13% 88

Other funds holding SBC

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

Cowen and Company's SBC Position: Q2 2023 in Review

Cowen and Company sold out of SBC Medical Group (SBC) in Q2 2023, closing a stake of 109,214 shares — an estimated $1.14M sold.

Cowen and Company first reported a position in SBC in Q1 2023 and held it in 1 quarter. The position peaked at $1.14M in Q1 2023. 13 funds tracked by Wall St. Rank hold SBC as of Q2 2023.

  • Cowen and Company reported no remaining SBC Medical Group position as of Q2 2023 after selling out during the quarter.
  • Cowen and Company sold 109,214 SBC Medical Group shares in Q2 2023, an estimated $1.14M.
  • Cowen and Company first reported a position in SBC Medical Group in Q1 2023 and held it in 1 quarter.
  • Cowen and Company's SBC Medical Group position peaked at $1.14M in Q1 2023.
  • 13 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.